Cibc Private Wealth Group, LLC Corcept Therapeutics Inc Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 855 shares of CORT stock, worth $29,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
855
Previous 1,075
20.47%
Holding current value
$29,155
Previous $27,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
311Shares Held
88.3MCall Options Held
1.07MPut Options Held
973K-
Black Rock Inc. New York, NY16.5MShares$564 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.55MShares$326 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.24MShares$281 Million11.51% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.91MShares$236 Million0.4% of portfolio
-
Parallel Advisors, LLC3.82MShares$130 Million3.2% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $3.65B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...